ResearchMoz

Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research
Published Date » 2013-08-30
No. Of Pages » 84
 
 This report studies the global market for companion diagnostics from two perspectives – companion diagnostics by indication and by geography. The market for companion diagnostics by indication includes sub-segments such as breast cancer, lung cancer, colorectal cancer, gastric cancer, melanoma and others (HIV, Thalassemia). By geography, the companion diagnostics market has been divided into four regions, namely, North America, Europe, Asia-Pacific and RoW. Market size and forecast for each segment and sub-segment has been provided for the period 2011 to 2019 in terms of USD million, with 2012 as the base year. The compounded annual growth rate (CAGR) for each market segment has been provided for the forecast period (2013 to 2019). 
   
 The report also contains a section on...
Table of Contents

Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation
1.4 List Of Abbreviations

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Introduction
3.2 Market Drivers
3.2.1 Rising Need For Companion Diagnostics Along With Targeted Therapies
3.2.2 Increasing Demand As Well As Developmental Efforts Towards Personalized Medicine
3.2.3 The Pharmacoeconomic Advantage: Reduced Drug Development Costs
3.2.4 Increasing Cancer Incidence Worldwide
3.2.5 Impact Analysis Of Market Drivers
3.3 Market Restraints
3.3.1 Effect Of Influence Of Advocacy Groups And Clinical Societies
3.3.2 Prolonged Developmental And Approval Phases
3.3.3 Impact Analysis Of Market Restraints
3.4 Market Opportunities
3.4.1 Expansion Into Newer Indication Areas
3.5 Porter’s Five Force Analysis: Global Companion Diagnostics Market
3.5.1 Bargaining Power Of Buyers
3.5.2 Bargaining Power Of Suppliers
3.5.3 Threat Of Substitutes
3.5.4 Threat Of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Companion Diagnostics Market, By Geography, 2012

Chapter 4 Companion Diagnostics Market, By Indications, 2011 - 2019 (USD Million)
4.1 Introduction
4.1.1 Comparative Analysis: Global Companion Diagnostics Market, By Indication, 2012 & 2019 (Value %)
4.1.2 Breast Cancer
4.1.3 Lung Cancer
4.1.4 Colorectal Cancer
4.1.5 Gastric Cancer
4.1.6 Melanoma
4.1.7 Others (HIV, Thalassemia)

Chapter 5 Companion Diagnostics Market, By Geography, 2011 - 2019 (USD Million)
5.1 Overview
5.1.1 Comparative Analysis: Global Companion Diagnostics Market, By Geography, 2012 & 2019 (Value %)
5.2 North America
5.2.1 North America Companion Diagnostics Market Size And Forecast, 2011 - 2019 (USD Million)
5.3 Europe
5.3.1 Europe Companion Diagnostics Market Size And Forecast, 2011 - 2019 (Usd Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Companion Diagnostics Market Size And Forecast, 2011 - 2019 (USD Million)
5.5 Rest Of The World (Row)
5.5.1 Row Companion Diagnostics Market Size And Forecast, 2011 - 2019 (USD Million)

Chapter 6 Competitive Landscape
6.1 Market Share By Key Players, 2012 (%)

Chapter 7 Recommendations
7.1 Changing Business Models of Pharmaceutical and Diagnostics Manufacturers
7.2 Investing in Emerging Economies

Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Agendia N.V.
8.2.1 Company Overview
8.2.2 Product Portfolio
8.2.3 Business Strategies
8.2.4 Recent Developments
8.3 Agilent Technologies, Inc.,
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 Biogenex Laboratories, Inc.
8.4.1 Company Overview
8.4.2 Product Portfolio
8.4.3 Business Strategies
8.4.4 Recent Developments
8.5 Ge Healthcare Ltd.
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 Genomic Health, Inc.
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Developments
8.7 Laboratory Corporation Of America Holdings (Labcorp)
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.5 Recent Developments
8.8 Life Technologies Corporation
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 Qiagen N.V.
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments
8.10 Resonance Health Analysis Services Pty Ltd.
8.10.1 Company Overview
8.10.2 Product Portfolio
8.10.3 Business Strategies
8.10.4 Recent Developments
8.11 Roche Holdings Ag
8.11.1 Company Overview
8.11.2 Financial Overview
8.11.3 Product Portfolio
8.11.4 Business Strategies
8.11.5 Recent Developments
8.12 Siemens Healthcare
8.12.1 Company Overview
8.12.2 Financial Overview
8.12.3 Product Portfolio
8.12.4 Business Strategies
8.12.5 Recent Developments

List of Tables


TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Companion Diagnostics Market
TABLE 3 Impact Analysis of Market Drivers
TABLE 4 Impact Analysis of Market Restraints
TABLE 5 Global Companion Diagnostics Market, by Indications, Size and Forecast, 2011 - 2019 (USD Million)
TABLE 6 Global Companion Diagnostics Market, by Geography, Size and Forecast, 2011 - 2019 (USD Million)

List of Figures


FIG. 1 Companion Diagnostics Market Segmentation
FIG. 2 Global Companion Diagnostics Market, by Indication, 2012 (USD Million)
FIG. 3 Porter’s Five Force Analysis: Global Companion Diagnostics Market
FIG. 4 Market Attractiveness Analysis: Global Companion Diagnostics Market, by Geography, 2012
FIG. 5 Comparative Analysis: Global Companion Diagnostics Market, by Indications, 2012 & 2019 (Value %)
FIG. 6 Global Breast Cancer Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 7 Global Lung Cancer Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 8 Global Colorectal Cancer Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 9 Global Gastric Cancer Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 10 Global Melanoma Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 11 Global Other Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 12 Comparative Analysis: Global Companion Diagnostics Market, by Geography, 2012 & 2019 (Value %)
FIG. 13 North American Market for Companion Diagnostics, Size and Forecast, 2011–2019 (USD Million)
FIG. 14 European Market for Companion Diagnostics, Size and Forecast, 2011– 2019 (USD Million)
FIG. 15 Asia-Pacific Market for Companion Diagnostics, Size and Forecast, 2011–2019 (USD Million)
FIG. 16 RoW Market for Companion Diagnostics, Size and Forecast, 2011–2019 (USD Million)
FIG. 17 Market Share Analysis: Companion Diagnostics Market, 2012 (%)
FIG. 18 Annual Revenues: Abbott Laboratories,  2010–2012 (USD Million)
FIG. 19 Annual Revenues: Agilent Technologies, Inc., 2010–2012 (USD Million)
FIG. 20 Annual Revenues: GE Healthcare, 2010–2012 (USD Million)
FIG. 21 Annual Revenues: Genomic Health, Inc.,  2010–2012 (USD Million)
FIG. 22 Annual Revenues: LabCorp,  2010–2012 (USD Million)
FIG. 23 Annual Revenues: Life Technologies Corporation, 2010–2012 (USD Million)
FIG. 24 Annual Sales: Qiagen N.V., 2010–2012 (USD Million)
FIG. 25 Annual Revenues: Roche Holdings AG, 2010–2012 (USD Million) (1Swiss Franc = 1.09 USD) (USD Million)
FIG. 26 Annual Revenues: Siemens Healthcare, 2010–2012 (USD Million)

Upcoming Reports:

DNA Sequencing Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
By - Transparency Market Research
The global DNA sequencing market is forecast to grow to $6.6 billion over the year 2016 at the compounded annual growth rate of 17.5% as a result of emerging technologies in this field and its use in a number of applications.   DNA sequencing industry is segmented into instruments and consumables, services, and workflow products. Instruments and consumables segment are the rapidly emerging segments accounting for about $2.2 billion by the year 2016. Services segment is expected to grow significantly and reach market value of $3.5 billion with CAGR of 29% over the year 2016....
Poland: woven fabrics market
By - Williams and Marshal Strategy
18. In the same way, the report presents an elaborate overview of the main market participants, the price fluctuations, the growth and demand drivers of the market and the factors, influencing its development. Last but not least, the report presents a general overview of the economy of Poland in 2008-2012 and a forecast for its development in the medium term. The report on the woven fabrics market in Poland includes: Analysis and dynamics of the economy of Poland; Forecast for the development of the economy of Poland; Analysis and forecast of market volume and dynamics; Volume,...
Nucleic Acid Testing Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Nucleic acid tests are performed in order to detect the presence of viral DNAs or RNAs in blood samples of patients. Three major processes involved in NAT are sample pooling and nucleic acid (NA) extraction, target NA amplification and target amplicon NA detection.Major NAT technologies include polymerase chain reaction (PCR), strand displacement amplification (SDA), ligase chain reaction (LCR), transcription-mediated amplification (TMA) and nucleic acid sequence based amplification (NASBA). Based on its major applications, NAT market can be classified into five major segments namely...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Pepsi Limon, A Brand New Addition to the Pepsi Portfolio
May 22, 2015  
To add a new dose of excitement to its cola offering, Pepsi has come up with the all new Pepsi Limon. This is a new flavored cola, which according to the company is manufactured with just the appropriate amount of real lime juice. The idea for the drink was inspired from the escalating preference of the Hispanic consumers. To satisfy the taste urges of the consumers, the new Pepsi Limon will...
India’s Auto Exports Register Record High Figures in 2014-15
May 21, 2015  
In the fiscal year 2014-15, Indian factories exported a record number of 3.5 million vehicles, which is 15% higher than what they managed a year back. However, domestic sales rose by only 5% since last financial year, with 2.6 million units being sold.  Exports of utility vehicles, commercial vehicles, cars and two- wheelers have increased every year since 2000. But domestic car...
Turkey’s Labor Dispute Affects Ford’s Production
May 21, 2015  
With the ongoing labor dispute in Turkey, Ford’s Turkish manufacturing facility has been hit. Ford Otosan, a joint venture between the company and Turkey’s Koc Holding, mentioned that due to supply problems, production has been temporary stalled at its plants located at Yenikoy and Golcuk in northwestern part of the country. Earlier this week, production at Tofas and Oyak Renault,...
International Automakers Slashing Prices in China
May 21, 2015  
With a slowing Chinese economy, the international automakers are cutting prices of vehicles to be sold in the nation. This has hit the profit margins of the automakers who are struggling with a slowdown in demand.  Last week saw Ford Motor Co. and General Motors slashing their prices on Chinese models. It closely follows rival Volkswagen AG’s move last month to offer...
Century Old Vancouver Sheet Metal Enterprise Shutters
May 21, 2015  
A Vancouver based metal works business in operation for almost 100 years, known for custom metal works shuttered this week.  The business known as Main Sheet Metal Works, a fabrication shop for sheet-metal on Main Street which is wedged between Pacific Central Station and Chinatown has existed for more than ninety years.  As commented by a third generation member of...